First Light Asset Management as of Sept. 30, 2017
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 52 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 8.5 | $27M | 2.4M | 11.13 | |
| AtriCure (ATRC) | 7.3 | $23M | 1.0M | 22.37 | |
| Immunomedics | 5.8 | $18M | 1.3M | 13.98 | |
| Array BioPharma | 5.7 | $18M | 1.5M | 12.30 | |
| Harvard Bioscience (HBIO) | 4.9 | $15M | 4.1M | 3.75 | |
| Omnicell (OMCL) | 4.8 | $15M | 298k | 51.05 | |
| Model N (MODN) | 4.0 | $13M | 852k | 14.95 | |
| Nektar Therapeutics (NKTR) | 3.8 | $12M | 503k | 24.00 | |
| Entellus Medical Cm | 3.7 | $12M | 633k | 18.46 | |
| Shire | 3.6 | $11M | 75k | 153.14 | |
| Teligent | 3.1 | $10M | 1.5M | 6.71 | |
| Oxford Immunotec Global | 3.0 | $9.4M | 562k | 16.80 | |
| Ligand Pharmaceuticals In (LGND) | 2.7 | $8.6M | 63k | 136.16 | |
| Medicines Company | 2.6 | $8.2M | 220k | 37.04 | |
| Halozyme Therapeutics (HALO) | 2.5 | $7.7M | 446k | 17.37 | |
| Veracyte (VCYT) | 2.3 | $7.4M | 842k | 8.77 | |
| Heron Therapeutics (HRTX) | 2.0 | $6.4M | 394k | 16.15 | |
| Dynavax Technologies (DVAX) | 1.9 | $5.9M | 274k | 21.50 | |
| K2m Group Holdings | 1.9 | $5.8M | 275k | 21.21 | |
| Nevro (NVRO) | 1.7 | $5.4M | 60k | 90.88 | |
| Quidel Corporation | 1.7 | $5.4M | 123k | 43.86 | |
| Globus Med Inc cl a (GMED) | 1.7 | $5.3M | 179k | 29.72 | |
| Intersect Ent | 1.7 | $5.3M | 170k | 31.15 | |
| NxStage Medical | 1.6 | $5.1M | 184k | 27.60 | |
| Bluebird Bio (BLUE) | 1.6 | $5.0M | 36k | 137.34 | |
| Bio-techne Corporation (TECH) | 1.5 | $4.7M | 39k | 120.89 | |
| HealthStream (HSTM) | 1.5 | $4.7M | 199k | 23.37 | |
| LHC | 1.4 | $4.6M | 65k | 70.93 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $3.6M | 23k | 152.04 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $3.0M | 32k | 93.07 | |
| Macrogenics (MGNX) | 0.9 | $2.8M | 152k | 18.48 | |
| Streamline Health Solutions (STRM) | 0.8 | $2.6M | 1.8M | 1.47 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.8 | $2.4M | 7.1k | 333.52 | |
| Enzo Biochem (ENZ) | 0.8 | $2.4M | 226k | 10.47 | |
| Codexis (CDXS) | 0.7 | $2.3M | 345k | 6.65 | |
| IRIDEX Corporation (IRIX) | 0.7 | $2.2M | 239k | 9.37 | |
| Ionis Pharmaceuticals (IONS) | 0.7 | $2.2M | 43k | 50.69 | |
| Celgene Corporation | 0.6 | $2.0M | 14k | 145.79 | |
| LeMaitre Vascular (LMAT) | 0.6 | $1.8M | 47k | 37.42 | |
| Powershares Etf Tr Ii s^p smcp hc po | 0.5 | $1.6M | 17k | 92.86 | |
| Alkermes (ALKS) | 0.5 | $1.5M | 30k | 50.85 | |
| Health Care SPDR (XLV) | 0.5 | $1.5M | 18k | 81.74 | |
| iShares Dow Jones US Medical Dev. (IHI) | 0.4 | $1.3M | 7.6k | 167.02 | |
| SPDR S&P Biotech (XBI) | 0.3 | $822k | 9.5k | 86.54 | |
| Abbvie (ABBV) | 0.1 | $370k | 4.2k | 88.96 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $335k | 6.7k | 49.85 | |
| Pfizer (PFE) | 0.1 | $306k | 8.6k | 35.76 | |
| Novartis (NVS) | 0.1 | $307k | 3.6k | 85.95 | |
| Johnson & Johnson (JNJ) | 0.1 | $284k | 2.2k | 130.10 | |
| Merck & Co (MRK) | 0.1 | $275k | 4.3k | 64.04 | |
| Amgen (AMGN) | 0.1 | $207k | 1.1k | 187.33 | |
| Dynatronics | 0.1 | $231k | 102k | 2.26 |
